Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.32 USD | -3.33% | -15.40% | -44.79% |
May. 23 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
May. 22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
Evolution of the average Target Price on Scholar Rock Holding Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Scholar Rock Holding Corporation
Raymond James | |
Jefferies & Co. | |
Wedbush | |
Piper Sandler | |
JPMorgan Chase | |
HC Wainwright | |
BMO Capital | |
Truist Securities |
EPS Revisions
- Stock Market
- Equities
- SRRK Stock
- Consensus Scholar Rock Holding Corporation